Vicapsys Life Sciences, Inc. (VICP)
0.40
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Vicapsys Life Sciences Free Cash Flow : -0.1292M for March 31, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.1292M |
| March 31, 2025 | -0.1241M |
| December 31, 2024 | -0.1217M |
| September 30, 2024 | -0.0231M |
| June 30, 2024 | -0.1423M |
| March 31, 2024 | -0.3604M |
| December 31, 2023 | -0.3671M |
| September 30, 2023 | -0.3848M |
| June 30, 2023 | -0.2663M |
| March 31, 2023 | -0.1322M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.2382M |
| September 30, 2022 | -0.3643M |
| June 30, 2022 | -0.5033M |
| March 31, 2022 | -0.4891M |
| December 31, 2021 | -0.444M |
| September 30, 2021 | -0.3211M |
| June 30, 2021 | -0.1444M |
| March 31, 2021 | -0.1005M |
| December 31, 2020 | -0.2629M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
| Sarepta Therapeutics, Inc. | 58.34M |
| Anixa Biosciences, Inc. | -7.376M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.0051M |
| Cash from Financing (Quarterly) | 0.135M |
| Free Cash Flow Per Share (Quarterly) | -0.0001 |
| Free Cash Flow to Equity (Quarterly) | -0.0504M |
| Free Cash Flow to Firm (Quarterly) | 0.0031M |
| Free Cash Flow Yield | -0.94% |